NEXPHORIA
CJC-1295 / Ipamorelin
Dual somatotropic axis stimulation. GHRH analog + selective GHS-R agonist.
Purchase Type
Fresh cold-chain delivery every 30 days
Format
For Research Use Only — Not For Human Consumption
This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.
This research blend combines CJC-1295 with Drug Affinity Complex (DAC) and Ipamorelin in equimolar proportions. CJC-1295 is a tetrasubstituted GHRH(1-29) analog with a DAC modification enabling covalent albumin binding, extending plasma half-life from minutes to days. Ipamorelin is a pentapeptide selective ghrelin mimetic (GHS-R1a agonist) with a highly selective GH-releasing profile.
Complete Your Protocol
Related compounds.
Side-by-Side Analysis
Compare CJC-1295 / Ipamorelin with Similar Compounds
View purity, MW, storage, and pricing side by side.
Frequently Bought Together
Complete Your Protocol
Researchers commonly order these compounds together. Convenient multi-compound ordering.
Growth Hormone
This itemCJC-1295 / Ipamorelin
10mg
$66
Growth Hormone
RecommendedIpamorelin
10mg
$54
Growth Hormone
CJC-1295
5mg
$46
3 items selected
Uncheck any item to customize your bundle. Discount applied automatically at checkout.
Research Journal
Related Research Articles
GHRP-2: The Potent Growth Hormone Releasing Peptide Research Guide
A comprehensive research guide to GHRP-2: GHSR-1a pharmacology, Arvat 1997 dose-response data, cortisol/ACTH co-stimulation profile, CJC-1295 No DAC synergy, tachyphylaxis mechanisms, and full preclinical protocol design for GH axis research.
CJC-1295 and Ipamorelin: The Complete Combination Research Guide
A comprehensive mechanistic and protocol guide for CJC-1295 No DAC + ipamorelin combination research: orthogonal receptor pharmacology, 8–12× synergistic GH amplification, published dosing data, IGF-1 endpoints, and full study design.
Ipamorelin and Fat Loss: GHSR-1a, Lipolysis, and Body Composition Research Protocols
A comprehensive research guide to GH secretagogue-mediated lipolysis using ipamorelin: mechanism, DIO rodent study design, EchoMRI endpoints, HPA-axis sparing advantage, CJC-1295 synergy, and 6 research design considerations.
Complete Your Protocol
Full GH Axis Protocol
CJC-1295 (DAC) provides a sustained GHRH signal; adding Ipamorelin triggers clean, selective GH pulses through a separate receptor pathway for amplified somatotropic response.
Growth Hormone
CJC-1295 / Ipamorelin
10mg
$66
Growth Hormone
Ipamorelin
10mg
$54